Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
- Conditions
- PJIPeriprosthetic Joint Infection
- Interventions
- Diagnostic Test: Microbial ID test
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 200
- Registration Number
- NCT05320354
- Locations
- 🇵🇹
Hospitalar do Porto,, Porto, Portugal
🇩🇪Charité Universitätsmedizin Berlin, Berlin, Germany
🇳🇱UMC Utrecht, Utrecht, Netherlands
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
Completed
- Conditions
- Respiratory Tract InfectionsCoinfection
- Interventions
- Other: No intervention
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 229
- Registration Number
- NCT05318235
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
Early Detection of Primary Antibody Deficiencies in Primary Care Facilities by an Algorithm Driven Selection of Serologic Testing in Individuals at Risk.
Completed
- Conditions
- Primary Antibody Deficiencies
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 104
- Registration Number
- NCT05310604
- Locations
- 🇳🇱
University Medical Center Utrecht, Utrecht, Netherlands
The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA)
Recruiting
- Conditions
- Brain Metastases, AdultBrain Neoplasms, Adult, Malignant
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 1000
- Registration Number
- NCT05267158
- Locations
- 🇳🇱
University Medical Center Utrecht, Utrecht, Netherlands
Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis
Phase 1
Recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 18
- Registration Number
- NCT05251870
- Locations
- 🇳🇱
Radboud University Medical Centre, Nijmegen, Netherlands
🇳🇱University Medical Centre Utrecht, Utrecht, Netherlands
🇳🇱Utrecht University, Utrecht, Netherlands
Breast Reconstruction and Neoadjuvant Radiotherapy
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Radiation: Neoadjuvant radiotherapy
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 20
- Registration Number
- NCT05216900
- Locations
- 🇳🇱
Maarse Wiesje, Bilthoven, Utrecht, Netherlands
Glioblastoma Targeted Treatment Option Maximization by WGS
Not Applicable
Recruiting
- Conditions
- Glioblastoma
- Interventions
- Diagnostic Test: whole genome sequencing
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 160
- Registration Number
- NCT05186064
- Locations
- 🇳🇱
Haaglanden Medisch Centrum, Den Haag, Netherlands
Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.
- Conditions
- SARS-CoV-2 VaccinationDown Syndrome
- Interventions
- Biological: Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)
- First Posted Date
- 2021-12-06
- Last Posted Date
- 2021-12-30
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 640
- Registration Number
- NCT05145348
- Locations
- 🇳🇱
UMC utrecht, Utrecht, Netherlands
Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma
Not Applicable
Recruiting
- Conditions
- Hepatocellular Carcinoma Non-resectable
- Interventions
- Device: Holmium-166 radioembolization
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 30
- Registration Number
- NCT05114148
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
Radioembolization in Elderly/ Fragile Patients With mCRC
Phase 2
Recruiting
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- Drug: Standard of care first-line systemic therapyDevice: radioembolization
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- UMC Utrecht
- Target Recruit Count
- 220
- Registration Number
- NCT05092880
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
© Copyright 2025. All Rights Reserved by MedPath